Jade Biosciences, Inc.
JBIO
$15.26
$0.040.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -129.61M | -127.41M | -- | -- | -- |
| Total Depreciation and Amortization | 27.00K | 18.00K | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.01M | 40.90M | -- | -- | -- |
| Change in Net Operating Assets | -438.00K | -8.20M | -- | -- | -- |
| Cash from Operations | -100.01M | -94.69M | -- | -- | -- |
| Capital Expenditure | -196.00K | -196.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -255.28M | -246.81M | -- | -- | -- |
| Cash from Investing | -255.48M | -247.01M | -- | -- | -- |
| Total Debt Issued | 0.00 | 0.00 | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 385.43M | 385.38M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -24.76M | -24.62M | -- | -- | -- |
| Cash from Financing | 360.67M | 360.77M | -- | -- | -- |
| Foreign Exchange rate Adjustments | -28.00K | -21.00K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.16M | 19.05M | -- | -- | -- |